Lipid signalling in disease

被引:983
作者
Wymann, Matthias P. [1 ]
Schneiter, Roger [2 ]
机构
[1] Univ Basel, Inst Biochem & Genet, Dept Biomed, CH-4058 Basel, Switzerland
[2] Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland
关键词
D O I
10.1038/nrm2335
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Signalling lipids such as eicosanoids, phosphoinositides, sphingolipids and fatty acids control important cellular processes, including cell proliferation, apoptosis, metabolism and migration. Extracellular signals from cytokines, growth factors and nutrients control the activity of a key set of lipid-modifying enzymes: phospholipases, prostaglandin synthase, 5-lipoxygenase, phosphoinositide 3-kinase, sphingosine kinase and sphingomyelinase. These enzymes and their downstream targets constitute a complex lipid signalling network with multiple nodes of interaction and cross-regulation. Imbalances in this network contribute to the pathogenesis of human disease. Although the function of a particular signalling lipid is traditionally studied in isolation, this review attempts a more integrated overview of the key role of these signalling lipids in inflammation, cancer and metabolic disease, and discusses emerging strategies for therapeutic intervention.
引用
收藏
页码:162 / 176
页数:15
相关论文
共 147 条
  • [1] The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307
    Aguirre, V
    Uchida, T
    Yenush, L
    Davis, R
    White, MF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) : 9047 - 9054
  • [2] Inhibition of PKC β by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients
    Aiello, LP
    Clermont, A
    Arora, V
    Davis, MD
    Sheetz, MJ
    Bursell, SE
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (01) : 86 - 92
  • [3] Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity
    Ali, IU
    Schriml, LM
    Dean, M
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (22): : 1922 - 1932
  • [4] Essential role for the p110δ phosphoinositide 3-kinase in the allergic response
    Ali, K
    Bilancio, A
    Thomas, M
    Pearce, W
    Gilfillan, AM
    Tkaczyk, C
    Kuehn, N
    Gray, A
    Giddings, J
    Peskett, E
    Fox, R
    Bruce, I
    Walker, C
    Sawyer, C
    Okkenhaug, K
    Finan, P
    Vanhaesebroeck, B
    [J]. NATURE, 2004, 431 (7011) : 1007 - 1011
  • [5] BALLA T, 2002, SCI STKE, pP13
  • [6] Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren
    Bandhuvula, Padmavathi
    Saba, Julie D.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2007, 13 (05) : 210 - 217
  • [7] Protein kinase Cβ deficiency increases fatty acid oxidation and reduces fat storage
    Bansode, Rishipal R.
    Huang, Wei
    Roy, Sanjit K.
    Mehta, Madhu
    Mehta, Kamal D.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (01) : 231 - 236
  • [8] Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion
    Barber, DF
    Bartolomé, A
    Hernandez, C
    Flores, JM
    Fernandez-Arias, C
    Rodríguez-Borlado, L
    Hirsch, E
    Wymann, M
    Balomenos, D
    Carrera, AC
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (01) : 589 - 593
  • [9] Signal transduction by tumor necrosis factor and its relatives
    Baud, V
    Karin, M
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (09) : 372 - 377
  • [10] FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis
    Baumruker, Thomas
    Billich, Andreas
    Brinkmann, Volker
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (03) : 283 - 289